Armata Pharmaceuticals, Inc. (ARMP) Misses Q2 EPS by 6c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q2 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• SPS Commerce hires Morgan Stanley, explores sale - Reuters